EcoDrugPlus

Bcl2 Like 1

Ensembl ID : ENSSLDG00000015833
Gene Symbol: BCL2L1
4 Cross references
226 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSSLDG00000011562
Gene Symbol: BCL2L1
3 Cross references
216 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSSLDG00000022713
Gene Symbol: BCR
3 Cross references
205 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSSLDG00000014110
Gene Symbol: BCR
3 Cross references
196 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSSLDG00000003900
Gene Symbol: BTK
3 Cross references
204 Possible Orthologues:

C-C Chemokine Receptor Type 9-Like

Ensembl ID : ENSSLDG00000007646
Gene Symbol: LOC111659189
3 Cross references
188 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSSLDG00000025208
Gene Symbol: CCR9
3 Cross references
193 Possible Orthologues:

C-X-C Motif Chemokine Receptor 1

Ensembl ID : ENSSLDG00000021008
Gene Symbol: CXCR1
1 Cross references
275 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSSLDG00000008053
Gene Symbol: CXCR4
3 Cross references
200 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSSLDG00000021503
Gene Symbol: CXCR4
4 Cross references
200 Possible Orthologues:

C-Reactive Protein-Like

Ensembl ID : ENSSLDG00000016587
Gene Symbol: LOC111652733
2 Cross references
415 Possible Orthologues:

C-Reactive Protein-Like

Ensembl ID : ENSSLDG00000016575
Gene Symbol: LOC111652735
2 Cross references
394 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).